Evidence map›Paper›PMID 31949484›Full record

ArticleJournal of Cancer2020

High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma.

Qiaoliang Zhu, Rongkui Luo, Jie Gu, Yingyong Hou, Zongwei Chen, Fengkai Xu, Lin Wang, Wei Mao, Chunlai Lu, Di Ge

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy.Medical oncology (Northwood, London, England) · 2025
    Review
  4. Article
  5. The mechanism ofTranslational cancer research · 2022
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Qiaoliang ZhuDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Rongkui LuoDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Jie GuDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Yingyong HouDepartment of Pathology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Zongwei ChenDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Fengkai XuDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Lin WangDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Wei MaoDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Chunlai LuDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Di GeDepartment of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
Fudan University · CNZhongshan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CXCR4lung adenosquamous carcinomaprognosis

Identifiers

PMID31949484
PMCPMC6959020
OpenAlexW3012232408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.